In this episode of Conversations in Healthcare, Mike Ward talks to Werner Lanthaler, CEO of Evotec, about how COVID-19 is bringing pharma leaders together and giving them collaborative momentum. Dr. Lanthaler is a co-founding member of COVID R&D, a global pharma industry initiative that has come together to rapidly respond to the pandemic. Together they are fast-tracking learnings and protocols to create a toolbox that can accelerate activities like clinical trials, re-purposing compounds and data sharing to address the crisis faster. COVID-19 has brought barriers down and truly brought the healthcare industry together, but could this forced synergy and learning be used to accelerate treatment creation in the future? Hosted on Acast. See acast.com/privacy for more information.